Recent studies suggested that GDF15 contributes to myeloma cell growth and chemoresistance and, even more importantly, that high levels of GDF15 are correlated with a poor prognosis in MM patients [6]. The gene discussed is GDF15; the disease is Miyoshi myopathy.